Cargando…
A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma
Immunotherapy targeting immune checkpoint molecules, programmed cell death 1 (PD-1) and PD-ligand 1 (PD-L1), using therapeutic antibodies has been widely used for some human malignancies in the last 5 years. A costimulatory receptor, PD-1, is expressed on T cells and suppresses effector functions wh...
Autores principales: | Maekawa, Naoya, Konnai, Satoru, Takagi, Satoshi, Kagawa, Yumiko, Okagawa, Tomohiro, Nishimori, Asami, Ikebuchi, Ryoyo, Izumi, Yusuke, Deguchi, Tatsuya, Nakajima, Chie, Kato, Yukinari, Yamamoto, Keiichi, Uemura, Hidetoshi, Suzuki, Yasuhiko, Murata, Shiro, Ohashi, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567082/ https://www.ncbi.nlm.nih.gov/pubmed/28827658 http://dx.doi.org/10.1038/s41598-017-09444-2 |
Ejemplares similares
-
Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma
por: Maekawa, Naoya, et al.
Publicado: (2016) -
Expression of PD-L1 on Canine Tumor Cells and Enhancement of IFN-γ Production from Tumor-Infiltrating Cells by PD-L1 Blockade
por: Maekawa, Naoya, et al.
Publicado: (2014) -
Anti-Bovine Programmed Death-1 Rat–Bovine Chimeric Antibody for Immunotherapy of Bovine Leukemia Virus Infection in Cattle
por: Okagawa, Tomohiro, et al.
Publicado: (2017) -
In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection
por: Nishimori, Asami, et al.
Publicado: (2017) -
Cooperation of PD-1 and LAG-3 in the exhaustion of CD4(+) and CD8(+) T cells during bovine leukemia virus infection
por: Okagawa, Tomohiro, et al.
Publicado: (2018)